Copyright Reports & Markets. All rights reserved.

Global Canine Arthritis Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Canine Arthritis Therapeutics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Canine Arthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Non-Steroidal Anti-Inflammatory Drugs
    • 1.4.3 Opioids
    • 1.4.4 Stem Cell Therapy
  • 1.5 Market by Application
    • 1.5.1 Global Canine Arthritis Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Veterinary Hospitals and Clinics
    • 1.5.3 Retail Pharmacies
    • 1.5.4 Drug Stores
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Canine Arthritis Therapeutics Market Perspective (2015-2026)
  • 2.2 Canine Arthritis Therapeutics Growth Trends by Regions
    • 2.2.1 Canine Arthritis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Canine Arthritis Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Canine Arthritis Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Canine Arthritis Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Canine Arthritis Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Canine Arthritis Therapeutics Players by Market Size
    • 3.1.1 Global Top Canine Arthritis Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Canine Arthritis Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Canine Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Canine Arthritis Therapeutics Market Concentration Ratio
    • 3.2.1 Global Canine Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Canine Arthritis Therapeutics Revenue in 2019
  • 3.3 Canine Arthritis Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Canine Arthritis Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Canine Arthritis Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Canine Arthritis Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2021-2026)

5 Canine Arthritis Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Canine Arthritis Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Canine Arthritis Therapeutics Market Size (2015-2020)
  • 6.2 Canine Arthritis Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Canine Arthritis Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Canine Arthritis Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Canine Arthritis Therapeutics Market Size (2015-2020)
  • 7.2 Canine Arthritis Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Canine Arthritis Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Canine Arthritis Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Canine Arthritis Therapeutics Market Size (2015-2020)
  • 8.2 Canine Arthritis Therapeutics Key Players in China (2019-2020)
  • 8.3 China Canine Arthritis Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Canine Arthritis Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Canine Arthritis Therapeutics Market Size (2015-2020)
  • 9.2 Canine Arthritis Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Canine Arthritis Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Canine Arthritis Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Canine Arthritis Therapeutics Market Size (2015-2020)
  • 10.2 Canine Arthritis Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Canine Arthritis Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Canine Arthritis Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Canine Arthritis Therapeutics Market Size (2015-2020)
  • 11.2 Canine Arthritis Therapeutics Key Players in India (2019-2020)
  • 11.3 India Canine Arthritis Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Canine Arthritis Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Canine Arthritis Therapeutics Market Size (2015-2020)
  • 12.2 Canine Arthritis Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Canine Arthritis Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Canine Arthritis Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Elanco (Eli Lilly and Company)
    • 13.1.1 Elanco (Eli Lilly and Company) Company Details
    • 13.1.2 Elanco (Eli Lilly and Company) Business Overview and Its Total Revenue
    • 13.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Therapeutics Introduction
    • 13.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Therapeutics Business (2015-2020))
    • 13.1.5 Elanco (Eli Lilly and Company) Recent Development
  • 13.2 Boehringer Ingelheim
    • 13.2.1 Boehringer Ingelheim Company Details
    • 13.2.2 Boehringer Ingelheim Business Overview and Its Total Revenue
    • 13.2.3 Boehringer Ingelheim Canine Arthritis Therapeutics Introduction
    • 13.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2015-2020)
    • 13.2.5 Boehringer Ingelheim Recent Development
  • 13.3 Zoetis Inc
    • 13.3.1 Zoetis Inc Company Details
    • 13.3.2 Zoetis Inc Business Overview and Its Total Revenue
    • 13.3.3 Zoetis Inc Canine Arthritis Therapeutics Introduction
    • 13.3.4 Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2015-2020)
    • 13.3.5 Zoetis Inc Recent Development
  • 13.4 Vetoquinol S.A.
    • 13.4.1 Vetoquinol S.A. Company Details
    • 13.4.2 Vetoquinol S.A. Business Overview and Its Total Revenue
    • 13.4.3 Vetoquinol S.A. Canine Arthritis Therapeutics Introduction
    • 13.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2015-2020)
    • 13.4.5 Vetoquinol S.A. Recent Development
  • 13.5 Bayer AG
    • 13.5.1 Bayer AG Company Details
    • 13.5.2 Bayer AG Business Overview and Its Total Revenue
    • 13.5.3 Bayer AG Canine Arthritis Therapeutics Introduction
    • 13.5.4 Bayer AG Revenue in Canine Arthritis Therapeutics Business (2015-2020)
    • 13.5.5 Bayer AG Recent Development
  • 13.6 Aratana Therapeutics Inc
    • 13.6.1 Aratana Therapeutics Inc Company Details
    • 13.6.2 Aratana Therapeutics Inc Business Overview and Its Total Revenue
    • 13.6.3 Aratana Therapeutics Inc Canine Arthritis Therapeutics Introduction
    • 13.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2015-2020)
    • 13.6.5 Aratana Therapeutics Inc Recent Development
  • 13.7 Norbrook Laboratories Limited
    • 13.7.1 Norbrook Laboratories Limited Company Details
    • 13.7.2 Norbrook Laboratories Limited Business Overview and Its Total Revenue
    • 13.7.3 Norbrook Laboratories Limited Canine Arthritis Therapeutics Introduction
    • 13.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2015-2020)
    • 13.7.5 Norbrook Laboratories Limited Recent Development
  • 13.8 VetStem Biopharma
    • 13.8.1 VetStem Biopharma Company Details
    • 13.8.2 VetStem Biopharma Business Overview and Its Total Revenue
    • 13.8.3 VetStem Biopharma Canine Arthritis Therapeutics Introduction
    • 13.8.4 VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2015-2020)
    • 13.8.5 VetStem Biopharma Recent Development
  • 13.9 Dechra Pharmaceuticals Plc
    • 13.9.1 Dechra Pharmaceuticals Plc Company Details
    • 13.9.2 Dechra Pharmaceuticals Plc Business Overview and Its Total Revenue
    • 13.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Introduction
    • 13.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2015-2020)
    • 13.9.5 Dechra Pharmaceuticals Plc Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Canine Arthritis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Canine Arthritis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Elanco (Eli Lilly and Company)
    Boehringer Ingelheim
    Zoetis Inc
    Vetoquinol S.A.
    Bayer AG
    Aratana Therapeutics Inc
    Norbrook Laboratories Limited
    VetStem Biopharma
    Dechra Pharmaceuticals Plc

    Market segment by Type, the product can be split into
    Non-Steroidal Anti-Inflammatory Drugs
    Opioids
    Stem Cell Therapy
    Market segment by Application, split into
    Veterinary Hospitals and Clinics
    Retail Pharmacies
    Drug Stores

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Canine Arthritis Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Canine Arthritis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Canine Arthritis Therapeutics are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now